Method for preparing roflumilast intermediate

A technology of difluoromethylation and tetrabutylammonium fluoride, applied in the preparation of roflumilast, the intermediate of roflumilast and the field of preparation thereof, can solve the problem of high reagent cost and easy explosion of sodium nitrite , industrial production safety hazards and other issues, to achieve the effects of simple and easy availability of reagents, low reaction conditions and equipment requirements, and overcoming poor selectivity

Active Publication Date: 2014-01-29
BEIJING WINSUNNY PHARMA CO LTD
View PDF5 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When the nitro group is reduced to an amino group, the reducing agent used is palladium carbon, which has a high cost; in the diazotization process, the sodium nitrite used is prone to explosion, which brings hidden dangers to the safety of industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing roflumilast intermediate
  • Method for preparing roflumilast intermediate
  • Method for preparing roflumilast intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Preparation of methyl 3-formyl-4-difluoromethoxybenzoate

[0065] Dissolve 30.6g of phosphorus oxychloride and 36.5g of N,N-dimethylformamide (DMF) in 50mL of acetonitrile, stir at 0°C, add 15.2g of methyl 4-hydroxybenzoate, stir at 25°C, monitor the reaction by TLC Completely evaporate the solvent, add water, adjust the pH to 5-6 with aqueous sodium hydroxide solution, extract with ethyl acetate, dry over anhydrous magnesium sulfate, concentrate, and recrystallize with ethyl acetate to obtain 15.9 g of 3-formyl-4-hydroxy Methyl benzoate, yield 88.3%.

[0066] Dissolve 12.6g of methyl 3-formyl-4-hydroxybenzoate and 7.94g of benzyltriethylammonium chloride in 50mL of DMF, stir, add 35mL of 0.4g / mL sodium hydroxide aqueous solution, and introduce Freon gas, The completion of the reaction was monitored by TLC. Water was added, extracted with dichloromethane, dried over anhydrous sodium sulfate, concentrated, and column chromatographed to obtain 12.3 g of methyl 3-formyl...

Embodiment 2

[0068] Preparation of methyl 3-formyl-4-difluoromethoxybenzoate

[0069] Dissolve 29.8g of thionyl chloride and 74.3g of N-methyl-N-phenylformamide in 100mL of tetrahydrofuran, stir at 2°C, add 15.2g of methyl 4-hydroxybenzoate, stir at 10°C, TLC monitors that the reaction is complete , evaporate the solvent, add water, adjust the pH to 5-6 with aqueous sodium carbonate solution, extract with ethyl acetate, dry over anhydrous magnesium sulfate, concentrate, and recrystallize with ethyl acetate to obtain 15.3g of 3-formyl-4-hydroxybenzoic acid Methyl ester, yield 85.0%.

[0070] Dissolve 12.6g of methyl 3-formyl-4-hydroxybenzoate and 5.17g of tetrabutylammonium iodide in 50mL of dioxane, stir, add 32.3g of diisopropylethylamine and 42.6g of difluorochloro Sodium acetate, continue to stir, TLC monitors that the reaction is complete, evaporate the solvent, add water, extract with ethyl acetate, dry over anhydrous sodium sulfate, concentrate, and column chromatography to obtain...

Embodiment 3

[0072] Preparation of methyl 3-formyl-4-difluoromethoxybenzoate

[0073] Dissolve 15.2g of methyl 4-hydroxybenzoate and 1.53g of tetramethylammonium bromide in 100mL of acetonitrile, add 25.4mL of 2.5g / mL sodium carbonate aqueous solution and 72.0g of methyl difluorochloroacetate, stir, and monitor the reaction by TLC Completely evaporate acetonitrile, add water, extract with dichloromethane, dry over anhydrous sodium sulfate, concentrate, and perform column chromatography to obtain 16.5 g of methyl 4-difluoromethoxybenzoate with a yield of 81.7%.

[0074] Dissolve 26.6g of magnesium chloride and 48.3g of N-formylmorpholine in 50mL of dimethyl sulfoxide, stir at 0°C, add 14.1g of methyl 4-difluoromethoxybenzoate, stir at 20°C, TLC monitors the reaction is complete, Evaporate the solvent, add water, adjust the pH to 5-6 with an aqueous potassium carbonate solution, extract with dichloromethane, dry over anhydrous magnesium sulfate, and recrystallize from ethyl acetate to obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a new roflumilast intermediate compound and a preparation method thereof, and application of the intermediate compound in preparing roflumilast. The roflumilast prepared from the intermediate has the advantages of mild reaction conditions, low requirements for reaction conditions and equipment, fewer byproducts, high product purity and yield and low production cost, does not use palladium on carbon, carbon monoxide or any other high-cost high-toxicity reagent, and is suitable for large-scale industrial production.

Description

[0001] technical field [0002] The invention relates to a chronic obstructive pulmonary disease pharmaceutical intermediate and a preparation method thereof, in particular to a roflumilast intermediate and a preparation method thereof, and the application of the intermediate in the preparation of roflumilast. Background technique [0003] Chronic Obstructive Pulmonary Disease (COPD) is a progressive and life-threatening lung disease, one of the "killers" of human health, it makes patients breathless and incapacitated. It is estimated that approximately 210 million people worldwide suffer from the disease, and COPD is expected to become the third leading cause of death globally by 2020. [0004] Roflumilast, developed by Nycomed of Switzerland, was approved by the European Union in July 2010. Its trade name is Daxas. It is the first selective phosphodiesterase 4 (PDE4) inhibitor, which can improve lung cancer. Function, reduce the acute attack rate of chronic bronchitis, us...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C69/92C07C67/30C07D213/75
CPCC07C67/31C07C67/343C07C69/92C07D213/75C07C69/84
Inventor 林国良刘志东韩硕耿玉先马跃中
Owner BEIJING WINSUNNY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap